Related Articles
Stanniocalcin 1 is a prognostic biomarker in glioma
RAB38 confers a poor prognosis, associated with malignant progression and subtype preference in glioma
RELB: A novel prognostic marker for glioblastoma as identified by population‑based analysis
Small interfering RNA targeting N‑cadherin regulates cell proliferation and migration in enzalutamide‑resistant prostate cancer
Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic value